Näky vs NexLife
Näky and NexLife both sell semaglutide and tirzepatide; this is how their prices, coverage and records differ.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
NexLife
Best for: coaching inside the $145/month rather than sold separately
Visit NexLife →If you are choosing between Näky and NexLife, price alone will not settle it. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. NexLife leads our six-part score, 7.3 to 6.3. One of the two has an FDA warning letter on record, covered below.
Näky vs NexLife price
Näky and NexLife start at the same figure, $145 a month, so the entry price does not separate them. Look at what each price covers and at the per-drug prices below.
Drug by drug: Semaglutide costs the same at both, $145 a month; tirzepatide is cheaper at NexLife ($186 a month on a prepaid plan vs $295 a month).
Medications and formats
Both sell semaglutide and tirzepatide.
On format, Näky prices compounded injections and brand-name pens, while NexLife prices compounded injections.
If you want the FDA-approved brand rather than a compounded version, Näky is the only one of the two with a brand-name price.
Where each one treats patients
Neither Näky nor NexLife publishes the states it serves, so enter your state at the very start of each sign-up.
Pricing
Näky
NexLife
Plan ladder: $165 monthly, $149/mo 3-mo, $147/mo 6-mo, $145/mo 12-mo. $145 is the 12-month-plan rate, not a promo.
Plan ladder: $215 monthly, $195/mo 3-mo, $190/mo 6-mo, $186/mo 12-mo. $186 is the 12-month-plan rate, not a promo.
What each price covers
Both prices cover shipping.
NexLife's price also covers the clinician visit, the medication itself and coaching, which Näky does not claim.
Näky is silent on the clinician visit, the medication itself, lab work and coaching.
NexLife is silent on lab work.
That matters most for the drug: unless Näky confirms otherwise, budget for medication on top of its listed price.
Näky
Covered by the monthly price
Medication
Not stated
Clinician visits
Not stated
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
NexLife
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
In the price
Where each one scores higher
Overall, NexLife scores 7.3 and Näky 6.3 out of 10.
Näky is stronger on trust & safety (4.0 vs 3.5).
NexLife is stronger on user experience (7.5 vs 3.0) and support (8.5 vs 5.0).
Value, effectiveness and accessibility are within half a point.
Näky
6.3/10
NexLife
7.3/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
The FDA sent NexLife a warning letter dated June 8, 2026 (letter 730096), and it is still open.
Näky has no FDA warning letter on record with us.
Features & Coverage
| Feature | Näky | NexLife |
|---|---|---|
| Starting Price | $145/mo | $145/mo prepaid |
| Features | ✓8 features | 5 features |
| States Available | Not disclosed | Not disclosed |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | ✓None | 1 letter |
About Näky
Pricing at steady state stays behind the intake. Näky holds LegitScript approval and sells compounded semaglutide and compounded tirzepatide, adds an oral semaglutide drops product that few others carry, runs a GLP-1 microdose program separately, and offers NAD+ and Sermorelin on top. Getting started means a 3-minute assessment online, after which a licensed provider returns a treatment plan the same day. For the oral line a NAKY10 promo code is referenced.
Read our full Näky review →About NexLife
Compounded semaglutide starts at $145/mo and compounded tirzepatide at $186/mo. NexLife runs a telehealth platform, is LegitScript-certified, and says it works only with pharmacies that are LegitScript-certified and NABP-accredited.
Read our full NexLife review →Pros & Cons
Näky
What we like
- Semaglutide costs $145 a month, 22% below the $185 median for compounded semaglutide across the sellers we compare
- The monthly price stays the same as your dose goes up
- The monthly price includes shipping
- We found no FDA warning letters issued to Näky
Watch-outs
- Tirzepatide costs $295 a month, 18% above the $250 median for compounded tirzepatide across the sellers we compare
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
NexLife
What we like
- Semaglutide costs $145 a month, 22% below the $185 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $186 a month, 26% below the $250 median for compounded tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price stays the same as your dose goes up
- The monthly price includes the medication, clinician visits, shipping and coaching
- A live video visit with a clinician is required before a prescription, which is slower than a form and is the more careful intake
Watch-outs
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- The FDA has issued NexLife a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
NexLife wins this one, 7.3 to 6.3, above all for coaching inside the $145/month rather than sold separately.
Choose Näky if…
You want the lower starting price and an opening price near $145 a month.
Choose NexLife if…
You want coaching inside the $145/month rather than sold separately and an opening price near $145 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
DudeMeds
Compounded semaglutide at $175/month
From $175/mo
Get started →Oak
Semaglutide at $119/month, 37% below the typical price
From $119/mo
Get started →Trimi Health
Knowing which pharmacy fills the vial: it names VialsRx
From $99/mo
Get started →Näky vs NexLife: FAQ
Close alternatives to Näky and NexLife
- Näky vs altRX
- Näky vs Gala
- Näky vs Sprout Health
- Näky vs Aquivia Health
- NexLife vs ElitePhysiqMD
- NexLife vs Yucca Health
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.